Phase II, Dose Finding Study of GTx-758
NCT01393119
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
77
Enrollment
INDUSTRY
Sponsor class
Stopped
FDA Clinical Hold
Conditions
Prostate Cancer
Interventions
DRUG:
GTx-758
Sponsor
GTx